Burden of undiagnosed hypertension in sub-saharan africa: A systematic review and meta-analysis

Hypertension

Volumn 65, Issue 2, 2015, Pages 291-298

  Ataklte, Feven ^a   Erqou, Sebhat ^b,c   Kaptoge, Stephen ^d   Taye, Betiglu ^e   Echouffo Tcheugui, Justin B ^f,g   Kengne, Andre P ^h,i,j  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Veteran Affairs Pittsburgh Health Care System   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e Jamaica Estates   (United States)

^f EMORY UNIVERSITY   (United States)

^g MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

^h SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

ⁱ GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

Africa south of the Sahara; cardiovascular diseases; hypertension; review

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AFRICA SOUTH OF THE SAHARA; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; META ANALYSIS; POPULATION; PREVALENCE; PRIORITY JOURNAL; PUBLISHING; SELF REPORT; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; ADULT; AGE DISTRIBUTION; AGED; ATTITUDE TO HEALTH; FEMALE; HEALTH SURVEY; MALE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE;

EID: 84921597285     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04394     Document Type: Article

References (53)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.
2. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV, Van Bortel LM. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011;29:1243-1252.
3. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a systematic review. Hypertension. 2007;50:1012-1018.
4. Kengne AP, Ntyintyane LM, Mayosi BM. A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr. 2012;23:103-112.
5. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611-619.
6. Agyemang C. Rural and urban differences in blood pressure and hypertension in Ghana, West Africa. Public Health. 2006;120:525-533.
7. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J; South African Demographic and Health Coordinating Team. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens. 2001;19:1717-1725.
8. Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A. The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006;20:59-65.
9. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J, Eastwood JB. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004;43:1017-1022.
10. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009;54:77-83.
11. Msyamboza KP, Ngwira B, Dzowela T, Mvula C, Kathyola D, Harries AD, Bowie C. The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One. 2011;6:e20316.
12. Tesfaye F, Byass P, Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord. 2009;9:39.
13. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens. 2006;20:91-92.
14. Bovet P, Ross AG, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C, Whiting D, Paccaud F. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. Int J Epidemiol. 2002;31:240-247.
15. Mathenge W, Foster A, Kuper H. Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey. BMC Public Health. 2010;10:569.
16. Nshisso LD, Reese A, Gelaye B, Lemma S, Berhane Y, Williams MA. Prevalence of hypertension and diabetes among Ethiopian adults. Diabetes Metab Syndr. 2012;6:36-41.
17. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba southwestern Nigerian population: a population-based survey. Cardiovasc J Afr. 2010;21:26-31.
18. Peltzer K, Phaswana-Mafuya N. Hypertension and associated factors in older adults in South Africa. Cardiovasc J Afr. 2013;24:67-71.
19. Musinguzi G, Nuwaha F. Prevalence, awareness and control of hypertension in Uganda. PLoS One. 2013;8:e62236.
20. Pires JE, Sebastião YV, Langa AJ, Nery SV. Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control. BMC Public Health. 2013;13:90.
21. Usman A, Mebrahtu G, Mufunda J, Nyarang'o P, Hagos G, Kosia A, Ghebrat Y, Mosazghi A, Atanga SJ, Equbamichael MM. Prevalence of non-communicable disease risk factors in Eritrea. Ethn Dis. 2006;16:542-546.
22. van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C. Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens. 2013;31:1018-1024.
23. Hendriks ME, Wit FW, Roos MT, et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012;7:e32638.
24. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62:18-26.
25. Addo J, Smeeth L, Leon DA. Hypertensive target organ damage in Ghanaian civil servants with hypertension. PLoS One. 2009;4:e6672.
26. Dewhurst MJ, Dewhurst F, Gray WK, Chaote P, Orega GP, Walker RW. The high prevalence of hypertension in rural-dwelling Tanzanian older adults and the disparity between detection, treatment and control: a rule of sixths? J Hum Hypertens. 2013;27:374-380.
27. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED; SEARCH Collaboration. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012;7:e43400.
28. Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, Aspray TJ, Alberti KG. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000;18:145-152.
29. Fezeu L, Kengne AP, Balkau B, Awah PK, Mbanya JC. Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health. 2010;64:360-365.
30. Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N. Epidemiology of hypertension in low-income countries: a cross-sectional populationbased survey in rural Uganda. J Hypertens. 2011;29:1061-1068.
31. Maseko MJ, Norton GR, Majane OH, Molebatsi N, Woodiwiss AJ. Global cardiovascular risk profiles of untreated hypertensives in an urban, developing community in Africa. Cardiovasc J Afr. 2011;22:261-267.
32. Gama H, Damasceno A, Silva-Matos C, Diogo D, Azevedo A, Lunet N. Low prevalence of hypertension with pharmacological treatments and associated factors. Rev Saude Publica. 2013;47:301-308.
33. Baragou S, Djibril M, Atta B, Damorou F, Pio M, Balogou A. Prevalence of cardiovascular risk factors in an urban area of Togo: a WHO STEPSwise approach in Lome, Togo. Cardiovasc J Afr. 2012;23:309-312.
34. Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006;6:9.
35. Dzudie A, Kengne AP, Muna WF, et al; CCS Investigator Group. Prevalence, awareness, treatment and control of hypertension in a selfselected sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012;0:e001217.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
38. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J; Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302:412-423.
39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
40. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974-978.
41. Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart. 2013;99:1390-1397.
42. Cooper RS, Amoah AG, Mensah GA. High blood pressure: the foundation for epidemic cardiovascular disease in African populations. Ethn Dis. 2003;13:S48-S52.
43. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
44. Chow CK, Teo KK, Rangarajan S, et al; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959-968.
45. Kowal P, Arokiasamy P, Lopez Ridaura R, Yong J, Minicuci N, Chatterji S. Hypertension in developing countries. Lancet. 2012;380:1471.
46. World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis 2013. http://www. who. int/cardiovascular- diseases/publications/global-brief-hypertension/en/. Accessed August 31, 2014.
47. World Health Organization. The World Health Statistics 2012. http://www. who. int/gho/publications/world-health-statistics/2012/en/. Accessed August 31, 2014.
48. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;16:14-26.
49. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357-362.
50. Lekoubou A, Awah P, Fezeu L, Sobngwi E, Kengne AP. Hypertension, diabetes mellitus and task shifting in their management in sub-Saharan Africa. Int J Environ Res Public Health. 2010;7:353-363.
51. Luepker RV. WHO MONICA project: what have we learned and where to go from here? Public Health Reviews. 2012;33:373-396.
52. Janssens B, Van Damme W, Raleigh B, Gupta J, Khem S, Soy Ty K, Vun M, Ford N, Zachariah R. Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bull World Health Organ. 2007;85:880-885.
53. Peck R, Mghamba J, Vanobberghen F, Kavishe B, Rugarabamu V, Smeeth L, Hayes R, Grosskurth H, Kapiga S. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a crosssectional survey. Lancet Glob Health. 2014;2:e285-e292.